Hello, Serosep has detected that you are using an outdated version of Internet Explorer. If possible we strongly urge you to update your browser or switch over to Chrome or Firefox so you can enjoy the full user experience of our website and avail of all the features!
Close This Message'

Serosep Awarded H2020 Funding

Serosep was successfully awarded H2020 phase 1 funding under the SME instrument.

This project has received funding from the European Unions Horizon 2020 research and innovation programme under grant agreement no. 809670.


Serosep are beginning a feasibility study, identifying  an environmentally friendly alternative to revolutionise the use of formaldehyde in The Histopathology (human tissue) fixative market.

This project has received funding from the European Unions Horizon 2020 research and innovation programme under grant agreement no. 809670.

 

https://cordis.europa.eu/project/rcn/213889_en.html

Recent News

Serosep Generic News Image
Serosep Ltd are Recruiting
Serosep Ltd have a vacancy for a Field Service Engineer. for more details click on the link below. Closing date is 21st June, 201...
Read More
Serosep Generic News Image
Come see us at Medlab ME 2019
...
Read More